16th International Conference on Alzheimer’s Drug Discovery

16th International Conference on Alzheimer’s Drug Discovery

October 4-6, 2015

 

Hyatt Regency
Jersey City, NJ

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top-level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering. For complete program and registration information, please visit our conference website.

Program Outline

Sunday, October 4, 2015
5:00–7:00 pm
On-Site Pre-Registration

Monday, October 5, 2015
8:00–9:20 am
Breakfast, Welcome & Plenary Lecture: Neuroinflammation: Mechanisms and Targets

9:30–12:30 pm
SESSION I: Apolipoproteins and Neuroinflammation

12:30–1:30 pm
Lunch, Poster and Exhibitor Session

1:35–5:10 pm
SESSION II: Neuroprotection, Mitochondrial Function and Synaptic Plasticity

5:20–7:00 pm
Networking Reception & Poster and Exhibitor Session

Tuesday, October 6, 2015
8:00–9:20 am
Breakfast, Welcome & Plenary Lecture: Progress and Future Directions in Tau Imaging

9:10 am–12:35 pm
SESSION III: Translatable Biomarkers to Accelerate Clinical Development

12:35–1:25 pm
Lunch, Poster and Exhibitor Session

1:25–4:20 pm
SESSION IV: TAU TDP-43, Progranulin and Protein Clearance

4:20–4:30 pm
Closing Remarks